Nektar Therapeutics (NKTR)
36.31
+0.53
(+1.48%)
USD |
NASDAQ |
Oct 19, 13:58
Nektar Therapeutics Cash from Operations (Annual) : -208.51M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -208.51M |
| December 31, 2024 | -175.71M |
| December 31, 2023 | -192.61M |
| December 31, 2022 | -304.01M |
| December 31, 2021 | -412.66M |
| December 31, 2020 | -313.29M |
| December 31, 2019 | -328.68M |
| December 31, 2018 | 718.21M |
| December 31, 2017 | -80.41M |
| December 31, 2016 | -117.02M |
| December 31, 2015 | -73.08M |
| December 31, 2014 | -142.01M |
| December 31, 2013 | -38.53M |
| December 31, 2012 | -129.76M |
| December 31, 2011 | -113.74M |
| December 31, 2010 | -55.87M |
| Date | Value |
|---|---|
| December 31, 2009 | 39.74M |
| December 31, 2008 | -145.78M |
| December 31, 2007 | 146.30M |
| December 31, 2006 | -92.72M |
| December 31, 2005 | -78.00M |
| December 31, 2004 | -78.14M |
| December 31, 2003 | -76.20M |
| December 31, 2002 | -74.98M |
| December 31, 2001 | -50.77M |
| December 31, 2000 | -35.74M |
| December 31, 1999 | -15.33M |
| December 31, 1998 | -19.22M |
| December 31, 1997 | 4.979M |
| December 31, 1996 | -5.818M |
| December 31, 1995 | -5.325M |
| December 31, 1994 | -4.005M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Eli Lilly & Co. | 16.81B |
| Inovio Pharmaceuticals, Inc. | -88.63M |
| Tonix Pharmaceuticals Holding Corp. | -99.84M |
| Capricor Therapeutics, Inc. | -69.81M |
| Kyntra Bio, Inc. | -4.82M |